Last reviewed · How we verify
NCT03680859: GpR3
Gastroparesis Registry 3
trial in Gastroparesis in 406 participants. Completed in 13 May 2024.
13 May 2024
Quick facts
| Lead sponsor | Johns Hopkins Bloomberg School of Public Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 406 |
| Start date | 24 January 2019 |
| Primary completion | 13 May 2024 |
| Estimated completion | 13 May 2024 |
| Sites | 6 locations across United States |
Conditions studied
- Gastroparesis — all drugs for Gastroparesis →
- Diabetic Gastroparesis — all drugs for Diabetic Gastroparesis →
- Idiopathic Gastroparesis — all drugs for Idiopathic Gastroparesis →
Sponsor
Johns Hopkins Bloomberg School of Public Health
Who can join
18 and older, any sex, with Gastroparesis or Diabetic Gastroparesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to create a new registry of patients with gastroparesis in order to better understand the characteristics of patients with gastroparesis and follow how their condition changes over time. The data collected may improve the understanding of the condition to enable better diagnosis and treatment.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition.
Parkman HP, Blackford AL, Murray HB, Yates KP, et al · · 2023 · cited 7× · PMID 36871132 · DOI 10.1002/jpen.2493 -
Predominant Symptom in Gastroparesis: Relationships to Quality of Life, Treatments, and Outcome.
Parkman HP, Wilson LA, Hasler WL, Grover M, et al · · 2026 · PMID 41833524 · DOI 10.1111/nmo.70287
Verify or expand the search:
- PubMed search for NCT03680859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastroparesis
Currently open trials in the same condition.
- NCT04661215 — Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms · recruiting
- NCT07104214 — Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy · recruiting
- NCT07526935 — Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator · NA · active not recruiting
- NCT05981300 — GpCRC Pediatric Gastroparesis Registry 2 · recruiting
- NCT06580197 — The Role of AAT After Abdominal Surgery Based on RWS · recruiting
Other Johns Hopkins Bloomberg School of Public Health trials
Trials by the same sponsor.
- NCT07458230 — Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation: · Phase 3 · not yet recruiting
- NCT07227558 — Improving Information Sharing Between Family Caregivers and Home Care Aides · NA · recruiting
- NCT07536126 — Testing Non-Nutrition Menu Labels on Food Selections · NA · not yet recruiting
- NCT06426004 — Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland · NA · not yet recruiting
- NCT07344142 — Improving Digital Wellbeing in Saudi Adolescents · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03680859 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins Bloomberg School of Public Health
- Last refreshed: 24 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03680859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing